These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


64 related items for PubMed ID: 11069617

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effects of TNF-alpha on leukocyte adhesion molecule expressions in cultured human lymphatic endothelium.
    Sawa Y, Sugimoto Y, Ueki T, Ishikawa H, Sato A, Nagato T, Yoshida S.
    J Histochem Cytochem; 2007 Jul; 55(7):721-33. PubMed ID: 17371935
    [Abstract] [Full Text] [Related]

  • 23. Topical and transdermal delivery of antisense oligonucleotides.
    Brand RM.
    Curr Opin Mol Ther; 2001 Jun; 3(3):244-8. PubMed ID: 11497348
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Transdermal delivery of phosphorodiamidate Morpholino oligomers across hairless mouse skin.
    Pannier AK, Arora V, Iversen PL, Brand RM.
    Int J Pharm; 2004 May 04; 275(1-2):217-26. PubMed ID: 15081152
    [Abstract] [Full Text] [Related]

  • 32. IgG anti-melanocyte antibodies purified from patients with active vitiligo induce HLA-DR and intercellular adhesion molecule-1 expression and an increase in interleukin-8 release by melanocytes.
    Li YL, Yu CL, Yu HS.
    J Invest Dermatol; 2000 Dec 04; 115(6):969-73. PubMed ID: 11121127
    [Abstract] [Full Text] [Related]

  • 33. Topical application of silymarin reduces chemical-induced irritant contact dermatitis in BALB/c mice.
    Han MH, Yoon WK, Lee H, Han SB, Lee K, Park SK, Yang KH, Kim HM, Kang JS.
    Int Immunopharmacol; 2007 Dec 15; 7(13):1651-8. PubMed ID: 17996674
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A randomized, placebo controlled trial of an antisense oligodeoxynucleotide to intercellular adhesion molecule-1 in the treatment of severe rheumatoid arthritis.
    Maksymowych WP, Blackburn WD, Tami JA, Shanahan WR.
    J Rheumatol; 2002 Mar 15; 29(3):447-53. PubMed ID: 11908555
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. In vivo growth suppression of rat C6 glioma transplanted in rat brain using antisense oligonucleotide for microtubule-associated protein 1A messenger ribonucleic acid.
    Matsuno A, Katayama H, Murakami M, Nagashima T.
    Br J Neurosurg; 2004 Aug 15; 18(4):343-6. PubMed ID: 15702832
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Development of an oral formulation for ICAM-1 antisense oligonucleotides.
    Stepkowski SM, Chen W, Geary R, Wang ME, Condon T, Stecker K, Bennett CF.
    Transplant Proc; 2001 Aug 15; 33(1-2):387. PubMed ID: 11266874
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.